Blog

Shilpa Gupta: Philippe Spiess kicks off the session on rare GU cancers in Athens!

Photo collage of Shilpa Gupta & Philippe Spiess

Jul 7, 2024, 14:30

Shilpa Gupta: Philippe Spiess kicks off the session on rare GU cancers in Athens!

Shilpa Gupta shared a post on X:

“The amazing Philippe Spiess kicks off the session on rare GU cancers in Athens! The definition of ‘rare’ cancers depends on where one lives. Urgent need to tackle the unmet needs globally & get them the $$ & attention they deserve.”

Source: Shilpa Gupta/X

Dr. Shilpa Gupta is the Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Dr. Gupta’s extensive research focuses on novel drug development and biomarkers of response/resistance in bladder cancer, contributing to numerous published works and leadership roles in clinical trials.

Athens cancer cancer funding Cancer research global health disparities global healthcare GU Oncology OncoDaily Oncology Philippe Spiess Rare Cancers rare GU cancers Shilpa Gupta Unmet Needs

Richard Gere and Alejandra Gere to Join Second Global OncoThon on February 15 for Fight Against Childhood Cancer

Mesothelioma Guideline Updates from ASCO 2024: Key Advances in Diagnosis and Treatment

Oncologist Near Me - Lynn Schuchter: A Pioneering Leader in Cancer Care and Melanoma Research

NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%

Stanley Tucci and Throat Cancer: How He Went Against, How He Survived, and More